| 1 |
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Masahiro Kumada, Shinji Kihara, Satoru Sumitsuji et al. · Arteriosclerosis Thrombosis and Vascular Biology
|
2003 |
1,431 |
| 2 |
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
Makoto Kinoshita et al. · Journal of Atherosclerosis and Thrombosis
Open access |
21 Aug 2018 |
828 |
| 3 |
Clinical Genetic Testing for Familial Hypercholesterolemia
Amy Curry Sturm et al. · Journal of the American College of Cardiology
Open access |
30 Jul 2018 |
624 |
| 4 |
36th International Symposium on Intensive Care and Emergency Medicine
R. M. Bateman et al. · Critical Care
Open access2,440 authors |
Apr 2016 |
531 |
| 5 |
Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)
Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa et al. · Journal of Clinical Oncology
Open access |
28 Jul 2006 |
367 |
| 6 |
Effectiveness of BNCT for recurrent head and neck malignancies
Itsuro Kato, Koji Ono, Yoshinori Sakurai et al. · Applied Radiation and Isotopes
|
8 Jul 2004 |
327 |
| 7 |
Phase II clinical study of photodynamic therapy using mono-l-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung
Harubumi Kato, Kinya Furukawa, Masami Sato et al. · Lung Cancer
|
16 Jul 2003 |
325 |
| 8 |
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Tomonori Okamura et al. · Journal of Atherosclerosis and Thrombosis
Open access |
18 Dec 2023 |
303 |
| 9 |
Pulmonary Nodules at Chest CT: Effect of Computer-aided Diagnosis on Radiologists’ Detection Performance
Kazuo Awai, Kohei Murao, Akio Ozawa et al. · Radiology
|
Feb 2004 |
274 |
| 10 |
Requirement of Caspase-3(-like) Protease-mediated Hydrogen Peroxide Production for Apoptosis Induced by Various Anticancer Drugs
Siro Simizu, Minoru Takada, Kazuo Umezawa et al. · Journal of Biological Chemistry
Open access |
Oct 1998 |
268 |
| 11 |
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
Hideyuki Arita et al. · Acta Neuropathologica Communications
Open access |
8 Aug 2016 |
267 |
| 12 |
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
Gerald F. Watts et al. · Nature Reviews Cardiology
ReviewOpen access |
15 Jun 2023 |
250 |
| 13 |
Effect of Contrast Material Injection Duration and Rate on Aortic Peak Time and Peak Enhancement at Dynamic CT Involving Injection Protocol with Dose Tailored to Patient Weight
Kazuo Awai, Kumiko Hiraishi, Shinichi Hori · Radiology
|
2004 |
248 |
| 14 |
FGF-2 Stimulates Periodontal Regeneration
Masahiro Kitamura et al. · Journal of Dental Research
|
8 Nov 2010 |
248 |
| 15 |
Variations in the FTO gene are associated with severe obesity in the Japanese
Kikuko Hotta et al. · Journal of Human Genetics
Open access |
31 Mar 2008 |
246 |
| 16 |
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)
Yasuyoshi Ouchi et al. · Circulation
Open access |
22 Aug 2019 |
227 |
| 17 |
Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease
Tomonori Kimura, Kenji Hamase, Yurika Miyoshi et al. · Scientific Reports
Open access |
18 May 2016 |
224 |
| 18 |
Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
Shun Ishibashi, Shizuya Yamashita, Hidenori Arai et al. · Atherosclerosis
Open access |
26 Feb 2016 |
216 |
| 19 |
Periodontal Tissue Regeneration Using Fibroblast Growth Factor -2: Randomized Controlled Phase II Clinical Trial
Masahiro Kitamura et al. · PLoS ONE
Open access |
Jul 2008 |
205 |
| 20 |
Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease
Koji Ohashi et al. · Journal of the American College of Cardiology
Open access |
Apr 2004 |
203 |
| 21 |
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases
Shizuya Yamashita, Daisaku Masuda, Yūji Matsuzawa · Current Atherosclerosis Reports
Open access |
2020 |
190 |
| 22 |
Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial
Shun Ishibashi, Hidenori Arai, Koutaro Yokote et al. · Journal of clinical lipidology
Open access |
28 Oct 2017 |
189 |
| 23 |
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
Chantal A Lebbink, Thera P. Links, Agnieszka Czarniecka et al. · European Thyroid Journal
Open access |
13 Oct 2022 |
182 |
| 24 |
Aortic and Hepatic Enhancement and Tumor-to-Liver Contrast: Analysis of the Effect of Different Concentrations of Contrast Material at Multi–Detector Row Helical CT
Kazuo Awai, Koichi Takada, Hiromitsu Onishi et al. · Radiology
|
Sep 2002 |
164 |
| 25 |
Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
Eiichi Araki, Shizuya Yamashita, Hidenori Arai et al. · Diabetes Care
|
3 Jan 2018 |
163 |
| 26 |
Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia
Naoto Takahashi, Taiichi Kyo, Yasuhiro Maeda et al. · Haematologica
Open access |
16 Dec 2011 |
150 |
| 27 |
Postprandial Hyperlipidemia and Remnant Lipoproteins
Daisaku Masuda, Shizuya Yamashita · Journal of Atherosclerosis and Thrombosis
Open access |
7 Nov 2016 |
149 |
| 28 |
Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers
Hirotaka Osada, Yoshio Tatematsu, Yasushi Yatabe et al. · Oncogene
|
4 Apr 2002 |
147 |
| 29 |
Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects
Masahiro Kitamura et al. · Journal of Bone and Mineral Research
Open access |
7 Nov 2015 |
147 |
| 30 |
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
Gerald F. Watts, Samuel S. Gidding, Pedro Mata et al. · Nature Reviews Cardiology
ReviewOpen access |
23 Jan 2020 |
146 |
| 31 |
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
Jean‐Charles Fruchart et al. · Cardiovascular Diabetology
Open access |
4 Jun 2019 |
145 |
| 32 |
Smaller introducer sheaths for REBOA may be associated with fewer complications
William Arthur Teeter, Junichi Matsumoto, Koji Idoguchi et al. · The Journal of Trauma: Injury, Infection, and Critical Care
|
28 May 2016 |
143 |
| 33 |
Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population
Kikuko Hotta et al. · Journal of Human Genetics
|
23 Oct 2009 |
143 |
| 34 |
Role of disseminated intravascular coagulation in severe sepsis
Satoshi Gando et al. · Thrombosis Research
|
26 Apr 2019 |
139 |
| 35 |
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Hidenori Arai, Shizuya Yamashita, Koutaro Yokote et al. · Journal of Atherosclerosis and Thrombosis
Open access |
6 Apr 2018 |
137 |
| 36 |
Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia
Hidenori Arai, Shizuya Yamashita, Koutaro Yokote et al. · Atherosclerosis
Open access |
24 Mar 2017 |
127 |
| 37 |
Effects of clazosentan on cerebral vasospasm–related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients
Hidenori Endo, Yasushi Hagihara, Naoto Kimura et al. · Journal of neurosurgery
Open access |
8 Apr 2022 |
124 |
| 38 |
Fewer REBOA complications with smaller devices and partial occlusion: evidence from a multicentre registry in Japan
Yosuke Matsumura, Junichi Matsumoto, Hiroshi Kondo et al. · Emergency Medicine Journal
|
31 Aug 2017 |
123 |
| 39 |
Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi et al. · JAMA Network Open
Open access |
9 Feb 2024 |
122 |
| 40 |
Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells
Yuki Yokota, Takehiro Noda, Yuichiro Okumura et al. · Cancer Science
Open access |
15 Jan 2021 |
113 |
| 41 |
Diagnosis and Management of Sitosterolemia 2021
Hayato Tada, Akihiro Nomura, Masatsune Ogura et al. · Journal of Atherosclerosis and Thrombosis
Open access |
27 Apr 2021 |
111 |
| 42 |
Reconstruction with an Osteochondral Autograft for Advanced Osteochondritis Dissecans of the Elbow
Kozo Shimada, Takeshi Yoshida, Ken Nakata et al. · Clinical Orthopaedics and Related Research
|
Jun 2005 |
111 |
| 43 |
Second nation-wide study of atherosclerosis in infants, children and young adults in Japan
Masami Imakita, Chikao Yutani, Jack P. Strong et al. · Atherosclerosis
|
Apr 2001 |
110 |
| 44 |
Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse
Saiko Kurosawa, Tomohiko YAMAGUCHI, Shuich Miyawaki et al. · Haematologica
Open access |
15 Jul 2010 |
109 |
| 45 |
Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation—double-blind placebo-controlled trial
Tadashi Nakamura, Tohru Funahashi, Shizuya Yamashita et al. · Diabetes Research and Clinical Practice
|
Dec 2001 |
103 |
| 46 |
Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
Mariko Harada‐Shiba, Hidenori Arai, Hirotoshi Ohmura et al. · Journal of Atherosclerosis and Thrombosis
Open access |
20 Jan 2023 |
102 |
| 47 |
Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas
Hideyuki Arita et al. · Scientific Reports
Open access |
31 Jul 2018 |
101 |
| 48 |
Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database
Hajime Nagasu et al. · Diabetes Care
Open access |
30 Sep 2021 |
95 |
| 49 |
Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022
Mariko Harada‐Shiba, Akira Ohtake, Daisuke Sugiyama et al. · Journal of Atherosclerosis and Thrombosis
Open access |
19 Jan 2023 |
93 |
| 50 |
Guidance for Pediatric Familial Hypercholesterolemia 2017
Mariko Harada‐Shiba, Takao Ohta, Akira Ohtake et al. · Journal of Atherosclerosis and Thrombosis
Open access |
5 Feb 2018 |
92 |